TY - JOUR
T1 - Implementation of an emergency department-based clinical pharmacist transitions-of-care program
AU - Hohner, Elizabeth
AU - Ortmann, Melinda
AU - Murtaza, Umbreen
AU - Chopra, Sheeva
AU - Ross, Patricia A.
AU - Swarthout, Meghan
AU - Efird, Leigh
AU - Pherson, Emily
AU - Saheed, Mustapha
N1 - Publisher Copyright:
Copyright © 2016, American Society of Health-System Pharmacists, Inc. All rights reserved.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Purpose. The implementation of an emergency department (ED)-based clinical pharmacist transitions-of-care (TOC) program is described. Summary. The intervention program consisted of collaboration between ED and ambulatory care pharmacists to provide patient-specific comprehensive medication review and education in the ED setting and to help ensure a coordinated transition to the ambulatory care setting by scheduling an ambulatory pharmacy clinic or home-based visit. Patients who sought care at an adult ED for an exacerbation of asthma, chronic obstructive pulmonary disease (COPD), or congestive heart failure (CHF) were assessed for issues with medication adherence or administration technique, patient-specific concerns regarding medication use, access to medications at discharge, the need for modification of chronic therapy, contraindicated medications, and vaccination status, if applicable. The pharmacist then referred the patient to follow up in an ambulatory care pharmacy clinic or with the home-based medication management (HBMM) program. Of the 18 program participants who were referred to follow-up care, 5 successfully followed up with a pharmacist after ED discharge. The mean time from the ED visit to follow-up for these 5 patients was 16.6 ± 8.6 days. In addition, 5 patients followed up with their primary care provider within 30 days of the initial ED visit; 2 of these patients also followed up with a pharmacist. Within 30 days of the initial ED encounter, 4 patients had ED revisits. Conclusion. A TOC pharmacist-led program targeting patients who arrived at the ED with the chief complaint of asthma exacerbation, COPD, or CHF provided interventions from an ED or ambulatory care pharmacist as well as follow-up opportunities at outpatient clinics or an HBMM program.
AB - Purpose. The implementation of an emergency department (ED)-based clinical pharmacist transitions-of-care (TOC) program is described. Summary. The intervention program consisted of collaboration between ED and ambulatory care pharmacists to provide patient-specific comprehensive medication review and education in the ED setting and to help ensure a coordinated transition to the ambulatory care setting by scheduling an ambulatory pharmacy clinic or home-based visit. Patients who sought care at an adult ED for an exacerbation of asthma, chronic obstructive pulmonary disease (COPD), or congestive heart failure (CHF) were assessed for issues with medication adherence or administration technique, patient-specific concerns regarding medication use, access to medications at discharge, the need for modification of chronic therapy, contraindicated medications, and vaccination status, if applicable. The pharmacist then referred the patient to follow up in an ambulatory care pharmacy clinic or with the home-based medication management (HBMM) program. Of the 18 program participants who were referred to follow-up care, 5 successfully followed up with a pharmacist after ED discharge. The mean time from the ED visit to follow-up for these 5 patients was 16.6 ± 8.6 days. In addition, 5 patients followed up with their primary care provider within 30 days of the initial ED visit; 2 of these patients also followed up with a pharmacist. Within 30 days of the initial ED encounter, 4 patients had ED revisits. Conclusion. A TOC pharmacist-led program targeting patients who arrived at the ED with the chief complaint of asthma exacerbation, COPD, or CHF provided interventions from an ED or ambulatory care pharmacist as well as follow-up opportunities at outpatient clinics or an HBMM program.
UR - http://www.scopus.com/inward/record.url?scp=84981273761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84981273761&partnerID=8YFLogxK
U2 - 10.2146/ajhp150511
DO - 10.2146/ajhp150511
M3 - Article
C2 - 27440625
AN - SCOPUS:84981273761
SN - 1079-2082
VL - 73
SP - 1180
EP - 1187
JO - American Journal of Health-System Pharmacy
JF - American Journal of Health-System Pharmacy
IS - 15
ER -